RayzeBio Revenue and Competitors
Estimated Revenue & Valuation
- RayzeBio's estimated annual revenue is currently $44M per year.
- RayzeBio's estimated revenue per employee is $193,750
- RayzeBio's total funding is $754M.
Employee Data
- RayzeBio has 227 Employees.
- RayzeBio grew their employee count by 51% last year.
RayzeBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | SVP, Biology & Translational Medicine | Reveal Email/Phone |
4 | SVP, Chemistry Innovation | Reveal Email/Phone |
5 | SVP Clinical Operations | Reveal Email/Phone |
6 | SVP, Chemistry & Head Discovery | Reveal Email/Phone |
7 | SVP, Finance | Reveal Email/Phone |
8 | General Counsel | Reveal Email/Phone |
9 | SVP, Head Commercial and Business Operations | Reveal Email/Phone |
10 | SVP, Chemistry | Reveal Email/Phone |
RayzeBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is RayzeBio?
Leader in targeted radiopharmaceuticals to improving cancer patient survival. Broad pipeline of innovative drugs against solid tumor targets
keywords:N/A
$754M
Total Funding
227
Number of Employees
$44M
Revenue (est)
51%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RayzeBio News
San Diego-based RayzeBio, a pharmaceuticals company which says it is developing targeted radiopharmaceutical drugs for cancer, has raised $108M in its Series C funding. The company said it has now raised a total of $258M. The new funding was led by Venrock Healthcare Capital Partners and also in ...
RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical drugs for cancer, today announced a $108 million Series C financing led by Venrock Healthcare Capital Partners alongside new investors Perceptive Advisors, Vivo Capital, Acuta Capital ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $36.2M | 227 | 9% | N/A |
#2 | $52.7M | 228 | N/A | N/A |
#3 | $64M | 229 | 23% | N/A |
#4 | $36.7M | 230 | 8% | N/A |
#5 | $30.5M | 231 | -11% | N/A |